↓ Skip to main content

The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients

Overview of attention for article published in Supportive Care in Cancer, August 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
30 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
59 Mendeley
Title
The feasibility of dexamethasone omission in weekly paclitaxel treatment for breast cancer patients
Published in
Supportive Care in Cancer, August 2018
DOI 10.1007/s00520-018-4381-0
Pubmed ID
Authors

Ana Luísa de Castro Baccarin, Macilon Nonato Irene, Daniel de Iracema Gomes Cubero, Ariana Sales Luz, Suelen Nastri Castro, Renan Sordi, Luis Eduardo Silva Móz, Auro Del Giglio

X Demographics

X Demographics

The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 12%
Unspecified 6 10%
Student > Bachelor 6 10%
Researcher 6 10%
Other 5 8%
Other 8 14%
Unknown 21 36%
Readers by discipline Count As %
Medicine and Dentistry 14 24%
Unspecified 6 10%
Biochemistry, Genetics and Molecular Biology 5 8%
Nursing and Health Professions 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 4 7%
Unknown 22 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2022.
All research outputs
#1,889,660
of 25,758,695 outputs
Outputs from Supportive Care in Cancer
#255
of 5,123 outputs
Outputs of similar age
#37,731
of 342,954 outputs
Outputs of similar age from Supportive Care in Cancer
#13
of 104 outputs
Altmetric has tracked 25,758,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,123 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,954 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.